Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Canadian Journal of Diabetes
|
February 4, 2026
The IDEA Framework: A Consensus-Based Model for Integrating Continuous Glucose Monitoring into Pharmacy Practice for Diabetes Care
Aaron Sihota, Akshay B Jain, Alicia Chin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 13, 2024
Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
Gottfried Rudofsky, Hanan Amadid, Uffe Christian Braae, et al.
Lancet (London, England)
|
June 7, 2026
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Julio Rosenstock, Liana K Billings, Reena Gajria, et al.
International Journal of Clinical Practice
|
September 25, 2020
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance
Akshay B Jain, Amar Ali, Juan J Gorgojo Martínez, et al.
The Lancet. Diabetes & Endocrinology
|
June 7, 2026
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study
Vanita R Aroda, Raffaella Buzzetti, Stine-Mathilde Dalskov, et al.
International Journal of Environmental Research and Public Health
|
April 26, 2025
Impact of the COVID-19 Pandemic and Control Measures on Screening and Diagnoses of Type 2 Diabetes in British Columbia
Bushra Mahmood, Gordon Li, Julia Li, et al.
The Lancet. Diabetes & Endocrinology
|
June 7, 2026
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
John B Buse, Harpreet S Bajaj, Stine-Mathilde Dalskov, et al.
Mayo Clinic Proceedings
|
April 3, 2025
Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations
David C Klonoff, Lori Berard, Denise Reis Franco, et al.
Canadian Journal of Diabetes
|
June 15, 2023
Diabetes and Mental Health
, David J Robinson, Kimberley Hanson, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Canadian Journal of Diabetes
|
February 4, 2026
The IDEA Framework: A Consensus-Based Model for Integrating Continuous Glucose Monitoring into Pharmacy Practice for Diabetes Care
Aaron Sihota, Akshay B Jain, Alicia Chin, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
November 13, 2024
Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies
Gottfried Rudofsky, Hanan Amadid, Uffe Christian Braae, et al.
Lancet (London, England)
|
June 7, 2026
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Julio Rosenstock, Liana K Billings, Reena Gajria, et al.
International Journal of Clinical Practice
|
September 25, 2020
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance
Akshay B Jain, Amar Ali, Juan J Gorgojo Martínez, et al.
The Lancet. Diabetes & Endocrinology
|
June 7, 2026
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study
Vanita R Aroda, Raffaella Buzzetti, Stine-Mathilde Dalskov, et al.
International Journal of Environmental Research and Public Health
|
April 26, 2025
Impact of the COVID-19 Pandemic and Control Measures on Screening and Diagnoses of Type 2 Diabetes in British Columbia
Bushra Mahmood, Gordon Li, Julia Li, et al.
The Lancet. Diabetes & Endocrinology
|
June 7, 2026
Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study
John B Buse, Harpreet S Bajaj, Stine-Mathilde Dalskov, et al.
Mayo Clinic Proceedings
|
April 3, 2025
Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations
David C Klonoff, Lori Berard, Denise Reis Franco, et al.
Canadian Journal of Diabetes
|
June 15, 2023
Diabetes and Mental Health
, David J Robinson, Kimberley Hanson, et al.
Page
of 2